|
Book Detail
 |
Clinical Handbook of Psychotropic Drugs
Procyshyn, Ric M., Ed.
|
Previous ISBN (13): 9780889374966 Category: Psychopharmacology Publisher: Hogrefe Publishing
|
|
|
|
Synopsis:
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. - Independent, unbiased, up-to-date - now with Spravato (esketamine) - Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Potential interactions and side effects summarized in comparison charts - With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek - Clearly written patient information sheets available for download as printable PDF files New in this edition - Antipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategies - Antidepressants revised, including updates to use in pregnancy and SPARI drug interactions - Pharmacogenomics chapter fully revised with expanded dose adjustment recommendations - Chart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettes - Unapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazocine), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene) - Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazine - New formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, A
|
|
|
|
|
|
|